YCYijun Cheng

Yijun Cheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yijun Cheng has a total of 74 co-authors. Here are the top co-authors by number of shared publications:

  • Hanbing Shang

    Department of Neurosurgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China

    5 shared publications
  • Wenwen Lv

    Clinical Research Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    3 shared publications
  • Zhe Bao Wu

    Department of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    3 shared publications
  • Bin Chen

    Department of Neurosurgery, Ruijin Hospital Luwan Branch Shanghai Jiao Tong University School of Medicine Shanghai China

    2 shared publications
  • Da-Peng Wang

    Department of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    2 shared publications
  • Hao Tang

    Department of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    2 shared publications

Latest Publications

  • Open Access

    Comparison of different transplantation routes and timing for stem cell therapy in stroke

    by Qingdong Meng, Hao Deng, Ziqian Zhang, Yongxu Wei, Mingjian Liu, Bin Chen, Yijun Cheng, Hanbing Shang

    At present, the treatment methods for ischemic stroke are relatively limited. Both intravenous thrombolysis and arterial thrombectomy have narrow time window limitations and benefit only a small nu...

  • Open Access

    Bilateral visual failure with optic tract involvement in sellar-suprasellar lymphoma: illustrative case

    by Xiao-Yi Guo, Yijun Cheng

    BACKGROUND: Visual dysfunction related to sellar lesions is usually attributed to chronic compression of the optic chiasm, typically following an insidious, progressive course. Abrupt or disproportionately rapid visual failure should therefore prompt careful evaluation for alternative or additional mechanisms. OBSERVATIONS: A 69-year-old woman experienced progressive visual deterioration over 3 months, followed by near-complete bilateral visual loss within 1 week. Visual field testing showed severe bilateral generalized depression. Dedicated sellar enhanced MRI revealed a large sellar-suprasellar mass compressing the optic chiasm. In addition to mass effect, contrast-enhanced images demonstrated optic tract enhancement and avid leptomeningeal enhancement, raising concern for spread along the optic tracts and meningeal dissemination beyond the primary sellar-suprasellar region. Axial fluid-attenuated inversion recovery sequences further showed bilateral optic tract hyperintensity with signal abnormalities extending to the adjacent hypothalamic structures. The patient underwent endoscopic transsphenoidal tumor resection. Pathological examination confirmed aggressive B-cell lymphoma (CD20+, CD79a+, CD5+, Ki-67 index 90%). LESSONS: This case emphasizes that, in sellar lesions presenting with rapidly progressive visual loss, radiological assessment should extend beyond the sellar mass and optic chiasm to include the optic tracts and adjacent postchiasmatic visual pathway. https://thejns.org/doi/10.3171/CASE26610

  • PU.1 Inhibition Attenuates Neuroinflammation and Pyroptosis After Traumatic Brain Injury by Modulating Microglial Polarization

    by Yong Wu, Sixian Ma, Lerong Zhang, Feiyu Ding, Zhichao Qiu, Fang Liu, Yijun Cheng, Handong Wang

    Objective: The exact role of transcription factor PU.1 in traumatic brain injury (TBI) remains unclear. This study aims to investigate the role of PU.1 in microglial function and neuroinflammation following TBI. Methods: A combination of bioinformatic analysis of public sequencing data sets (GSE269748 and GSE128543), a mouse TBI model (controlled cortical impact), and in vitro experiments using LPS-stimulated BV2 microglial cells was used. The specific PU.1 inhibitor DB2313 was administered to assess its effects. RNA sequencing, reverse transcription-polymerase chain reaction (RT-PCR), Western blot, immunofluorescence staining, scratch wound assay, and phagocytic capacity assay were used. Results: PU.1 was significantly up-regulated in the sites of injured cortex post-TBI and LPS-treated microglia. Its inhibition by DB2313 attenuated microglial polarization towards the proinflammatory M1 phenotype, reduced the expression of inflammatory mediators, and suppressed microglial migration while enhancing phagocytosis. Mechanistically, PU.1 exacerbated neuroinflammation via the TLR4/MyD88/NF-κB signaling pathway and promoted NLRP3 inflammasome-Caspase-1-mediated pyroptosis. Conclusion: PU.1 is a key regulator of neuroinflammation and pyroptosis after TBI. Targeting PU.1 represents a promising therapeutic strategy to mitigate microglial-mediated inflammatory damage and improve outcomes following TBI.

  • Endoscopic surgery for noninvasive prolactinomas: A large multicenter, single-arm, retrospective study (PRLomaSaR)

    by Yijun Cheng, Yu Wang, Wenwen Lv, Gang Yang, Yazhuo Zhang, Kaiyu Guo, Jing Xie, Hao Tang, Weiting Gu, Jing Guo, et al.


  • Open Access

    Curcumin Driven Formation of Self-Cascade Nanoclusters from Urate Oxidase-H2S Donor Conjugates for Acute Gouty Arthritis Alleviation

    by Yuxuan Ge, Fan Rong, Zixin Wang, Yujia Lu, Yanwen Zhang, Yijun Cheng, Junsheng Chen, Yin Wang

    Gouty arthritis (GA) is a common arthritis characterized by abnormal deposition of monosodium urate (MSU) crystals in articular structures. Current clinical medications can only alleviate the inflammation caused by the acute GA temporarily, but have no solution to the deposition of MSU. To surmount this, urate oxidase (UOx) was initially modified with the phenylboronic acid-based self-immolative thiocarbamate through nucleophilic substitution, and then co-assembled with curcumin through boronate bond to form the platform (termed UBC). This way, the platform could not only directly eliminate the MSU, but also release the therapeutic gas hydrogen sulfide (H2S) triggered by the toxic by-product of UOx catalysis, hydrogen peroxide (H2O2). Synergized with curcumin, the inflammation could be effectively suppressed. In vivo experiments on an acute GA murine model also validated the potent therapeutic effect of the platform, mainly due to the synergistic effect of H2S and curcumin. We believe this strategy provides a novel approach for the treatment of inflammation-related diseases and novel insight into the construction of multi-functional therapeutic nanomaterials from enzymes and other biomolecules.

  • Open Access

    Risk Factor Analysis of Transient Ischemic Attack for Moyamoya Disease After a First Combined Revascularization Surgery

    by Shao Zhang, Jiangong Ma, Liming Zhao, Chaoyue Li, Shijie Xie, Xiaomeng Li, Wenwen Lv, Xiaobin Wang, Yijun Cheng


  • Initial Clinical Experience Using Naked-Eye 3D 4K Exoscope for Vestibular Schwannoma

    by Yijun Cheng, Zhe Bao Wu

    Traditionally, all vestibular schwannoma (VS) operation require the use of an operating microscope. More recently, the introduction of the exoscope with a 3-dimensional, high-definition (3D, 4K) display system has revolutionized neurosurgical techniques and illumination, benefiting to both neurosurgeons and patients. Herein, we report initial clinical experience using naked-eye 3D 4K exoscope for 2 VS cases using a retrosigmoid approach. Notably, the 4K monitor can automatically recognize the sticker on neurosurgeon’s head to construct subsequent adjustments, which further reduces the level of operation fatigue. Moreover, naked-eye 3D can provide more realistically stereoscopic vision and higher definition, which does not need to be filtered through 3D glasses. Through these 2 VS cases, we showed that the naked-eye 3D 4K exoscope is an effective tool for the tumor resection with the advantages of reasonable size, 3D visual perception, wider field of operative view, less cumbersome, and good ergonomics.


  • Open Access

    Carotid Endarterectomy Ameliorates Cognitive Impairment in Clinical and Experimental Unilateral Carotid Artery Stenosis

    by Yijun Cheng, Bin Chen, Miao Zhang, Zhenghong Chen, Mingjian Liu, Ziqian Zhang, Hao Tang, Dapeng Wang, Wenwen Lv, Biao Li, et al.

    Background: Carotid endarterectomy (CEA) is widely used to treat carotid artery stenosis (CAS). However, the effects of CEA on unilateral CAS‐induced cognitive impairment and the underlying mechanism remain poorly understood. Methods and Results: Thirteen patients diagnosed with unilateral severe CAS underwent pre‐ and post‐CEA assessments, including 18 fluoro‐2‐deoxy‐ d ‐glucose positron emission tomography/magnetic resonance imaging, cognitive assessments, and routine blood tests before and after CEA. Unilateral carotid common artery occlusion and ligation release (reperfusion) surgeries were performed in mice to mimic CAS and CEA. Cognitive function, cerebral blood flow, and white matter damage were evaluated in mice using the Morris water maze test, Doppler flowmetry, laser‐speckle imaging, diffusion tensor imaging, Luxol fast blue staining, transmission electron microscopy, and western blot assays post unilateral carotid common artery occlusion and reperfusion. Genomic sequencing of the white matter was performed to explore the potential underlying mechanism. CEA significantly enhanced the Montreal Cognitive Assessment scores in patients with CAS and preoperative cognitive impairment. Moreover, CEA led to notable improvements in cerebral blood flow, energy metabolism, and white matter integrity, while concurrently reducing blood inflammation. In the mouse model, reperfusion surgery alleviated cognitive deficits, increased cerebral blood flow, and alleviated white matter damage following unilateral carotid common artery occlusion. Furthermore, transcriptional surveys have revealed substantial alterations in the upregulation of Nrf2 signaling and metabolic pathways, coupled with the inhibition of neuroinflammation, cellular communication, and immune cell population signaling following reperfusion. Conclusions: CEA ameliorated CAS‐induced cognitive dysfunction by improving the cerebral functional structure. These beneficial effects may be attributed to their antioxidant and anti‐inflammatory properties.


  • Open Access

    Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas

    by Yijun Cheng, Dapeng Wang, Hao Tang, Debing Tong, Weiguo Zhao, Shaojian Lin, Hong Yao, Wenwen Lv, Xun Zhang, Li Xue, et al.

    Several subtypes of pituitary neuroendocrine tumors (PitNETs), such as acromegaly and Cushing’s disease, can result in hypertension. However, whether prolactinoma is associated with this complication remains unknown. Moreover, the effect of treatment with surgery or drugs on blood pressure (BP) is unknown. Herein, a retrospective study reviewed 162 patients with prolactinoma who underwent transsphenoidal surgery between January 2005 and December 2022. BP measurements were performed 1 day before and 5 days after surgery. Accordingly, patients’ medical characteristics were recorded. In addition, in situ rat and xenograft nude-mice prolactinoma models have been used to mimic prolactinoma. In vivo BP and serum prolactin (PRL) levels were measured after cabergoline (CAB) administration in both rats and mice. Our data suggest that surgery can effectively decrease BP in prolactinoma patients with or without hypertension. The BP-lowering effect was significantly associated with several variables, including age, sex, disease duration, tumor size, invasion, dopamine agonists (DAs)-resistance, recurrence, and preoperative PRL levels. Moreover, in situ and xenograft prolactinomas induced BP elevation, which was alleviated by CAB treatment without and with a statistical difference in rats and mice, respectively. Thus, surgery or CAB can decrease BP in prolactinoma, indicating that pre- and postoperative BP management becomes essential.